Uncertain effects of folic acid on disorders other than neural-tube defects;Onzekere effecten van foliumzuur op andere aandoeningen dan neuraalbuisdefecten

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 26, 2006, Pages 1439-1442

  Verhoef, P ^a   Katan, M B ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; PLACEBO; PYRIDOXINE;

CANCER INCIDENCE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CYANOCOBALAMIN DEFICIENCY; HUMAN; NEURAL TUBE DEFECT; RECURRENT DISEASE; REVIEW; SUPPLEMENTATION;

ANIMALS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; FOLIC ACID; FOLIC ACID DEFICIENCY; FOOD, FORTIFIED; HUMANS; NEOPLASMS; PRENATAL CARE; VITAMIN B 12 DEFICIENCY;

EID: 33746190696     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Ueland PM, Vollset SE. Homocysteine and folate in pregnancy. Clin Chem. 2004;50:1293-5.
2. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578-88.
3. Davey Smith G, Ebrahim S. Folate supplementation and cardiovascular disease. Lancet. 2005;366:167g-81.
4. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Poguel, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. N Engl J Med. 2006;354:1567-77.
5. Kloosterman J, Jong N de, Rompelberg CJM, Kranen HI van, Kampman E, Ocké MC. Foliumzuurverrijking: zowel preventie als bevordering van kanker. Ned Tijdschr Geneeskd. 2006;150:1443-8.
6. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285:2981-6.
7. Gucciardi E, Pietrusiak MA, Reynolds DL, Rouleau J. Incidence of neural tube defects in Ontario, 1986-1999. CMAJ. 2002;167:237-40.
8. Persad VL, Hof MC van den, Dubé IM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ. 2002;167:241-5.
9. Meijer WM, Walle HEK de. Verschillen in foliumzuurbeleid en prevalentie van neuralebuisdefecten in Europa; aanbevelingen voor voedselverrijking in een EUROCAT-rapport. Ned Tijdschr Geneeskd. 2005;149:2561-4.
10. Verhagen AAE, Sol JJ, Brouwer OF, Sauer PJ. Actieve levensbeë indiging bij pasgeborenen in Nederland; analyse van alle 22 meldingen uit 1997/'04. Ned Tijdschr Geneeskd. 2005;149:183-8.
11. Voedingsnormen: vitamine B6, foliumzuur en vitamine Bl2. Publicatienr 2003/04. Den Haag: Gezondheidsraad; 2003.
12. Voedingsraad/Gezondheidsraad. Vervolgadvies inzake foliumzuur-voorziening in relatie tot neurale buisdefecten. Den Haag: Vocdingsraad; 1993.
13. Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr. 2004;80:1123-8.
14. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer. 2005;113:825-8.
15. Donk M van den. The role of B-vitamins - gene interactions in colorectal carcinogenesis - a molecular epidemiological approach [proefschrift]. Wageningen: Wageningen Universiteit; 2005.
16. Charles D, Ness AR, Campbell D, Davey Smith G, Hall MH. Taking folate in pregnancy and risk of maternal breast cancer. BMJ. 2004;329:1375-6.
17. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003:348:891-9.
18. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DI, Bresalier RS, et al. A randomized intervention study of folic acid to prevent colorectal adenomas [abstract]. Proc Am Assoc Cancer Res. 2005;46:4399.
19. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Scheuten EG. MTHFR 677C→T polymorphism and risk of coronary heart disease: a metaanalysis. MTHFR Studies Collaboration Group. JAMA. 2002;288:2023-31.
20. Lewis SJ, Ebrahim S, Davey Smith G. Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ. 2005;331:1053.
21. Ellinson M, Thomas J, Patterson A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet. 2004;17:371-83.
22. Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia [Cochrane review], Cochrane Database Syst Rev. 2003;(4):CD004514.
23. Risico's van foliumzuurverrijking. Publicatienr 2000/21. Den Haag: Gezondheidsraad; 2000.
24. Dickinson CJ. Does folic acid harm people with vitamin B12 deficiency? QJM. 1995;88:357-64.
25. Mills JL, von Kohorn I, Conley MR, Zeller JA, Cox C, Williamson RE, et al. Low vitamin B12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am J Clin Nutr. 2003;77:1474-7.
26. Reyes-Engel A, Munoz E, Gaitan MJ, Fabre E, Gallo M, Dieguez JL, et al. Implications on human fertility of the 677C→T and 1298A→C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol Hum Reprod. 2002;8:952-7.
27. Whitehead AS. Changes in MTHFR genotype frequencies over time. Lancet. 1998;352:1784-5.